Organoids, AI, and the Future of Healthcare | Jason Burke

Organoids, AI, and the Future of Healthcare | Jason Burke

Miniature organs grown from cells. Artificial intelligence making increasingly complex healthcare decisions. Quantum computing. FDA-regulated data systems.

Science fiction is becoming remarkably close to scientific reality.

Jason Burke joins BioTalk Unzipped for a wide-ranging discussion of emerging technologies and how they could change drug discovery, clinical research, precision medicine, and healthcare.

The conversation begins with organoids, three-dimensional cell structures designed to reproduce important characteristics of human organs. Gregory, Chad, and Jason discuss their applications in research as well as the ethical questions that become particularly interesting when brain organoids enter the conversation.

Jason then explains his background and discusses the technologies he believes could materially transform clinical research.

The discussion moves into AI, data science, precision medicine, and quantum computing before addressing a challenge every organization eventually confronts: implementing powerful new technologies without sacrificing data integrity, regulatory compliance, or sound strategy.

The episode concludes with discussion of FDA expectations, 21 CFR Part 11, and why successful digital transformation requires more than simply adopting the newest technology.

Chapters

01:14 - Introduction to BioTalk Unzipped

03:30 - New News: Organoids and their applications

04:45 - Ethical questions surrounding brain organoids and biological computing

06:31 - Organoids in drug-discovery research and brain interfaces

08:59 - Brain training and neuroplasticity

10:51 - The impact of AI and data science in healthcare

11:18 - Jason’s background and emerging technologies transforming clinical research

13:43 - AI in precision medicine, quantum computing, and business growth

24:15 - FDA IT strategy and the challenges of implementing AI

26:32 - Technology strategy, prioritization, data integrity, and 21 CFR Part 11

Connect with Jason Burke

Jason Burke

https://www.linkedin.com/in/jasonburke/

Creo Inc.

https://www.creoinc.net/

Connect with the hosts

Dr. Chad Briscoe

https://www.linkedin.com/in/chadbriscoe/

Gregory Austin

https://www.linkedin.com/in/gregoryaustin1/

New News

The many uses of mini-organs:

https://www.technologyreview.com/2024/03/08/1089612/the-many-uses-of-mini-organs/

Image credits

Brain illustration: https://www.vecteezy.com/vector-art/658977-kawaii-cute-happy-brain-with-arms-and-legs

UFO: https://www.pinterest.com/pin/swampthingy--675891856570360044/

#Organoids #AI #QuantumComputing #HealthcareInnovation #DrugDiscovery #ClinicalResearch

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(45)

Why Gene Therapy Is Still So Hard to Manufacture at Scale | Phillip Ramsey

Why Gene Therapy Is Still So Hard to Manufacture at Scale | Phillip Ramsey

Why is gene therapy still so difficult to manufacture at scale after decades of progress?Phillip Ramsey, Chief Technical Officer at Sangamo Therapeutics, joins BioTalk Unzipped for a candid conversati...

8 Aug 11min

Her Daughter’s Brain Tumor Turned Her Into a Biotech Founder | Tracy Ryan

Her Daughter’s Brain Tumor Turned Her Into a Biotech Founder | Tracy Ryan

A mother’s search for answers to her daughter’s relentless brain tumor led her into natural killer cell biology, cancer immunotherapy, and biotech entrepreneurship.Sponsored by Leucentra, https://leuc...

20 Jul 1h 4min

The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi

The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi

Oncology drug development is becoming more complex, and bioanalysis can no longer be treated as simple drug measurement.Sponsored by Leucentra, https://leucentra.com/Inspired by science, empowered by ...

11 Jun 29min

Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker

Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker

Can artificial intelligence help make cancer therapies safer, more targeted, and more effective?In this episode of BioTalk Unzipped, Gregory Austin sits down with Dr. Daniel Reker, Assistant Professor...

25 Apr 50min

Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Why haven’t we cured cancer yet? A Genentech scientist explains the real reason.In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Bob Liu, Senior Principal Sci...

19 Mar 1h

The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney

The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney

Recorded October 31, 2025In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Kate Neville, immunologist turned seasoned biotech patent attorney at Marshall, Gers...

16 Feb 52min

Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins

Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins

In this episode of BioTalk Unzipped, hosts Gregory Austin and Dr. Chad Briscoe sit down with Glafabra CEO: Dr. Chris Hopkins, geneticist, biochemist, and biotech entrepreneur, to explore the science a...

22 Des 202549min

Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva

Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva

In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Binodh DeSilva, Senior Vice President of Bioanalysis at Ultragenyx Pharmaceutical, to explore the science and...

23 Okt 202531min

Populært innen Business og økonomi

stopp-verden
lydartikler-fra-aftenposten
dine-penger-pengeradet
rss-penger-polser-og-politikk
e24-podden
rss-borsmorgen-okonominyhetene
rss-skravla-gar
lederpodden
rss-pa-konto
utbytte
pengepodden-2
livet-pa-veien-med-jan-erik-larssen
morgenkaffen-med-finansavisen
finansredaksjonen
tid-er-penger-en-podcast-med-peter-warren
liberal-halvtime
rss-markedspuls-2
pengesnakk
rss-politisk-preik
okonomiamatorene